| Financial Year |
March 31 2023 |
| Monetary Funds |
670,775,059.50 |
| Held-for-trading Financial Assets |
3,726,312.92 |
| Notes Receivable |
45,767,026.29 |
| Accounts Receivable |
1,990,275,208.15 |
| Advances to Suppliers |
137,815,637.43 |
| Other Receivables |
31,330,180.82 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,072,160,392.63 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
100,339,505.91 |
| Other Current Assets |
22,971,779.34 |
| Total Current Assets |
4,592,449,573.76 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
152,074,096.91 |
| Long-term Equity Investment |
163,484,631.15 |
| Investment Properties |
137,464,110.24 |
| Fixed Assetes |
807,486,284.46 |
| Under-construction Projects |
15,463,408.22 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
104,056,220.96 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
513,331.60 |
| Deferred Income Tax Assets |
187,057,435.74 |
| Other Non-Current Assets |
59,072,204.16 |
| Sub-Total of Non-Current Assets |
1,653,002,264.12 |
| Total Assets |
6,245,451,837.88 |
| Short-Term Loans |
416,636,401.32 |
| Trading Financial liabilities |
-- |
| Notes Payable |
310,557,512.44 |
| Accounts Payable |
673,168,425.75 |
| Accounts Received In Advance |
11,056,569.92 |
| Employee Compensation Payable |
24,086,248.70 |
| Taxes Payable |
49,266,022.20 |
| Interest Payable |
-- |
| Dividend Payable |
27,006,528.80 |
| Other payables |
810,830,417.95 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
55,082,191.71 |
| Other Current Liabilities |
30,470,012.26 |
| Sub-Total of Current Liabilities |
2,613,115,748.97 |
| Long-term Loans |
27,224,599.42 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
20,288,698.02 |
| Special Payable |
-- |
| Estimatied Liabilities |
79,516,690.21 |
| Deferred Income Tax Liabilities |
5,769,371.19 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
161,636,157.59 |
| Total Liabilities |
2,774,751,906.56 |
| Paid-In Capital(Or Share Stock) |
651,560,000.00 |
| Capital Surplus |
194,850,042.31 |
| Surplus Reserve |
233,316,151.34 |
| LESS:Treasury Stock |
45,150,000.00 |
| Undistributed Profits |
2,294,430,084.95 |
| Minority Stockholder's Interest |
150,197,642.40 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,320,502,288.92 |
| Owner's Equity（Stockholder's Equity） |
3,470,699,931.32 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
6,245,451,837.88 |
